Inventor
WACHTER ERIC A
US46 patents
⚠️ This page may combine multiple inventors who share the name “WACHTER ERIC A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROVECTUS PHARMATECH INC
15 patentsUS7390668B2Jun 24, 2008
Intracorporeal medicaments for photodynamic treatment of disease
PROVECTUS PHARMATECH INC22 citations92
US7402299B2Jul 22, 2008
Intracorporeal medicaments for photodynamic treatment of disease
PROVECTUS PHARMATECH INC12 citations83
US10471144B2Nov 12, 2019
Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
PROVECTUS PHARMATECH INC5 citations82
US11071781B2Jul 27, 2021
Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
PROVECTUS PHARMATECH INC1 citations73
US7384623B1Jun 10, 2008
High energy phototherapeutic agents
PROVECTUS PHARMATECH INC8 citations72
US11058664B2Jul 13, 2021
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC1 citations69
US7427389B2Sep 23, 2008
Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
PROVECTUS PHARMATECH INC2 citations63
US7338652B2Mar 4, 2008
Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents
PROVECTUS PHARMATECH INC2 citations63
US7863047B2Jan 4, 2011
Intracorporeal medicaments for photodynamic treatment of disease
PROVECTUS PHARMATECH INC1 citations62
US12377068B2Aug 5, 2025
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC0 citations59
US11974980B2May 7, 2024
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC0 citations59
US12133840B2Nov 5, 2024
Halogenated xanthene composition and method for treating hematologic cancers
PROVECTUS PHARMATECH INC0 citations58
US11419844B2Aug 23, 2022
Halogenated xanthene composition and method for treating hematologic cancers
PROVECTUS PHARMATECH INC0 citations58
US12064507B2Aug 20, 2024
Composition and method for oral treatment of leukemia
PROVECTUS PHARMATECH INC0 citations55
US11975106B2May 7, 2024
Uses of halogenated xanthenes in oncology and virology
PROVECTUS PHARMATECH INC0 citations55
PHOTOGEN INC
7 patentsUS6042603AMar 28, 2000
Method for improved selectivity in photo-activation of molecular agents
PHOTOGEN INC120 citations99
US5832931ANov 10, 1998
Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
PHOTOGEN INC136 citations99
US5829448ANov 3, 1998
Method for improved selectivity in photo-activation of molecular agents
PHOTOGEN INC170 citations99
US5998597ADec 7, 1999
Method for improved selectivity in photo-activation of molecular agents
PHOTOGEN INC90 citations98
US6331286B1Dec 18, 2001
Methods for high energy phototherapeutics
PHOTOGEN INC69 citations95
US6525862B2Feb 25, 2003
Methods and apparatus for optical imaging
PHOTOGEN INC38 citations92
US6519076B2Feb 11, 2003
Methods and apparatus for optical imaging
PHOTOGEN INC25 citations92
PROVECTUS PHARMACEUTICALS INC
4 patentsUS9839688B2Dec 12, 2017
Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
PROVECTUS PHARMACEUTICALS INC5 citations82
US9808524B2Nov 7, 2017
Combination of local and systemic immunomodulative therapies for melanoma and liver cancer
PROVECTUS PHARMACEUTICALS INC5 citations82
US9422260B2Aug 23, 2016
Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one(Rose Bengal) and related xanthenes
PROVECTUS PHARMACEUTICALS INC2 citations59
US9273022B2Mar 1, 2016
Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′, 4′, 5′7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (Rose Bengal) and related xanthenes
PROVECTUS PHARMACEUTICALS INC2 citations58
UT BATTELLE LLC
3 patentsUS6336366B1Jan 8, 2002
Piezoelectrically tunable resonance frequency beam utilizing a stress-sensitive film
UT BATTELLE LLC141 citations98
US6263736B1Jul 24, 2001
Electrostatically tunable resonance frequency beam utilizing a stress-sensitive film
UT BATTELLE LLC96 citations96
US6311557B1Nov 6, 2001
Magnetically tunable resonance frequency beam utilizing a stress-sensitive film
UT BATTELLE LLC65 citations94
XANTECH PHARMACEUTICALS INC
3 patentsUS7036516B1May 2, 2006
Treatment of pigmented tissues using optical energy
XANTECH PHARMACEUTICALS INC25 citations92
US6991776B2Jan 31, 2006
Intracorporeal medicaments for high energy phototherapeutic treatment of disease
XANTECH PHARMACEUTICALS INC11 citations83
US6986740B2Jan 17, 2006
Ultrasound contrast using halogenated xanthenes
XANTECH PHARMACEUTICALS INC3 citations62